Medicines Distribution Consent




NEW ZEALAND GAZETTE, No. 76

5 MAY 2005

Manufacturers:
Hoffmann – La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada

New Zealand Sponsor:
Roche Products (New Zealand) Limited

Product:
Pegasys RBV (Combination Product)

Active Ingredient:
Peginterferon alfa-2a 360µg/mL

Dosage Form:
Solution for injection

Manufacturer:
F.Hoffman – La Roche AG, Basel, Switzerland

Active Ingredient:
Ribavirin 200mg

Dosage Form:
Film-coated tablet

Manufacturers:
Hoffmann – La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada

New Zealand Sponsor:
Roche Products (New Zealand) Limited

Product:
Roferon-A RBV (Combination Product)

Active Ingredient:
Interferon alfa-2a 30MIU/mL

Dosage Form:
Solution for injection

Manufacturers:
Hoffmann – La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada
Weimer Pharma GmbH, Rastatt, Germany

Active Ingredient:
Ribavirin 200mg

Dosage Form:
Film-coated tablet

Manufacturers:
Hoffmann – La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada
Weimer Pharma GmbH, Rastatt, Germany

New Zealand Sponsor:
Roche Products (New Zealand) Limited

Product:
Roferon-A RBV (Combination Product)

Active Ingredient:
Interferon alfa-2a 6MIU/mL

Dosage Form:
Solution for injection

Manufacturers:
F.Hoffmann – La Roche Limited, Basel, Switzerland
Hoffmann – La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada

Active Ingredient:
Ribavirin 200mg

Dosage Form:
Film-coated tablet

Manufacturers:
F.Hoffmann – La Roche Limited, Basel, Switzerland
Hoffmann – La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada

New Zealand Sponsor:
Roche Products (New Zealand) Limited

Product:
Sensipar

Active Ingredient:
Cinacalcet hydrochloride 33mg

Dosage Form:
Film-coated tablet

New Zealand Sponsor:
Amgen Australia Pty Limited

Manufacturer:
Patheon Inc, Mississauga, Ontario, Canada

Product:
Sensipar

Active Ingredient:
Cinacalcet hydrochloride 66mg

Dosage Form:
Film-coated tablet

New Zealand Sponsor:
Amgen Australia Pty Limited

Manufacturer:
Patheon Inc, Mississauga, Ontario, Canada

Product:
Sensipar

Active Ingredient:
Cinacalcet hydrochloride 99mg

Dosage Form:
Film-coated tablet

New Zealand Sponsor:
Amgen Australia Pty Limited

Manufacturer:
Patheon Inc, Mississauga, Ontario, Canada

Dated this 26th day of April 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go2628

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2005, No 76


Gazette.govt.nz PDF NZ Gazette 2005, No 76





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
26 April 2005
Medicines, Distribution Consent, Medicines Act 1981
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
Medicines, Distribution Consent, Medicines Act 1981